Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-14 |
2024-03 |
-0.3 |
N/A |
N/A |
N/A |
2024-03-06 |
2023-12 |
-0.31 |
-0.33 |
-0.02 |
-6.45% |
2023-11-07 |
2023-09 |
-0.62 |
-0.95 |
-0.33 |
-53.23% |
2023-08-08 |
2023-06 |
-0.7 |
-0.81 |
-0.11 |
-15.71% |
2023-05-09 |
2023-03 |
-0.71 |
-0.88 |
-0.17 |
-23.94% |
2023-03-21 |
2022-12 |
-0.76 |
-0.58 |
0.18 |
23.68% |
Date |
Firm |
Action |
From |
To |
2023-09-25 |
Cantor Fitzgerald |
Upgrade |
Overweight |
Overweight |
2023-09-14 |
Oppenheimer |
Upgrade |
Outperform |
Outperform |
2023-08-30 |
Cantor Fitzgerald |
Upgrade |
Overweight |
Overweight |
2023-07-10 |
Cantor Fitzgerald |
Upgrade |
|
Overweight |
2023-05-24 |
Oppenheimer |
Upgrade |
|
Outperform |
2023-03-23 |
Oppenheimer |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2022-03-28 |
ABINGWORTH, L.L.P. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Purchase |
2024-03-31 |
BHATNAGAR ANISH |
Chief Executive Officer |
152.79K |
Sale |
2023-09-27 |
CARLYLE GROUP, INC. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Conversion of Exercise of derivative security |
2024-03-31 |
HIRANO PATRICIA C |
Officer |
50.92K |
Sale |
2024-03-31 |
MACKANESS JAMES H |
Chief Financial Officer |
62.95K |
Sale |
2024-01-07 |
MARIO ERNEST B |
Director |
145.32K |
Stock Gift |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Perceptive Advisors Llc |
2.21M |
9.47M |
22.09% |
2023-06-29 |
Carlyle Group Inc. |
1.20M |
5.15M |
12.02% |
2023-06-29 |
Nantahala Capital Management, LLC |
649.84K |
2.79M |
6.50% |
2023-06-29 |
AIGH Capital Management LLC |
364.31K |
1.56M |
3.65% |
2023-06-29 |
Birchview Capital, LP |
245.13K |
1.05M |
2.45% |
2023-06-29 |
J. Goldman & Co., L.P. |
120.80K |
518.23K |
1.21% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
49.94K |
214.24K |
0.50% |
2023-09-29 |
SEI Institutional Managed Tr-Small Cap Growth Fund |
18.80K |
554.79K |
0.19% |
2023-05-30 |
Fidelity Extended Market Index Fund |
17.27K |
91.02K |
0.17% |
2023-09-29 |
SEI Institutional Managed Tr-Small Cap Fund |
14.30K |
421.99K |
0.14% |
2023-05-30 |
Fidelity Total Market Index Fund |
11.22K |
59.14K |
0.11% |
2023-09-29 |
SEI Institutional Investment Tr-Small Cap Fund |
6.90K |
203.68K |
0.07% |
Split |
Date |
1 : 15 |
2022-08-26 |
1 : 5 |
2017-10-06 |